Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion type Assertion NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_head.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion wasGeneratedBy ECO_0000203 NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_provenance.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion wasDerivedFrom befree-2016 NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_provenance.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion SIO_000772 24031028 NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_provenance.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion evidence source_evidence_literature NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_provenance.
- NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_assertion description "[In contrast, however, castration-resistant bone metastases exhibit reduced levels of SOCS2 in comparison with localized or hormone naive, untreated metastatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110113.RASOme3AT8PK0kaVCdz_s8nqfIswWrUpaR-UyO6IiJK0g130_provenance.